Global Anti-acne Preparations 麻豆原创 Research Report 2024

Publication ID:

PB508240178

Publication Date:

August 31, 2024

Pages:

117

Publisher:

MRRPB5

Countries:

Global [1]

USD 2,900.00

Healthcare [2]

Pharma & Healthcare [3]

Description:

Anti-acne preparations are a class of drugs or skin care products used to treat acne. Acne is a common skin disease that usually occurs during adolescence and is caused by blocked hair follicles and excessive secretion of sebaceous glands, manifesting as skin lesions such as comedones, papules, pustules, and nodules. Anti-acne preparations can work through a variety of mechanisms, including antibacterial, anti-inflammatory, regulating sebum secretion, and promoting keratin exfoliation.
The global Anti-acne Preparations market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of %during the forecast period 2024-2030.
North American market for Anti-acne Preparations is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Anti-acne Preparations is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of Anti-acne Preparations include Hefei Cube Pharmaceutical Co., Ltd., Jiangsu Xinfu Pharmaceutical Co., Ltd., Anhui Guosen Pharmaceutical Co., Ltd., Jiangsu Jibei Pharmaceutical Co., Ltd., Heilongjiang Fuhe Pharmaceutical Group Co., Ltd., Jiangsu Xiaolin Pharmaceutical Co., Ltd., Sichuan Mingxin Pharmaceutical Co., Ltd., Jiangsu Fubang Pharmaceutical Co., Ltd., Wuhan Nuoan Pharmaceutical Co., Ltd., Fujian Yongan Pharmaceutical Co., Ltd., etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Anti-acne Preparations, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Anti-acne Preparations.
The Anti-acne Preparations market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2021 as the base year, with history and forecast data for the period from 2017 to 2028. This report segments the global Anti-acne Preparations market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Anti-acne Preparations manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
By Company
Hefei Cube Pharmaceutical Co., Ltd.
Jiangsu Xinfu Pharmaceutical Co., Ltd.
Anhui Guosen Pharmaceutical Co., Ltd.
Jiangsu Jibei Pharmaceutical Co., Ltd.
Heilongjiang Fuhe Pharmaceutical Group Co., Ltd.
Jiangsu Xiaolin Pharmaceutical Co., Ltd.
Sichuan Mingxin Pharmaceutical Co., Ltd.
Jiangsu Fubang Pharmaceutical Co., Ltd.
Wuhan Nuoan Pharmaceutical Co., Ltd.
Fujian Yongan Pharmaceutical Co., Ltd.
Shanghai Zhengda General Pharmaceutical Co., Ltd.
Jiangxi Hillconta Pharmaceutical Co., Ltd.
Guangdong Hengjian Pharmaceutical Co., Ltd.
Guangdong China Resources Shunfeng Pharmaceutical Co., Ltd.
Galderma
Bausch Health
Pure Source
Zydus Lifesciences Ltd
Glenmark Pharmaceuticals
Sun Pharma
Galderma Pharma SA
Alembic Pharmaceuticals
CABTREO
AdvaCare Pharma
Segment by Type
Erythromycin
Tretinoin
Adapalene
Benzoyl Peroxide
Clindamycin
Sulfur Ointment
Isotretinoin
Segment by Application
Hospital
Clinic
Other
Consumption by Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Europe
Germany
France
U.K.
Italy
Russia
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East and Africa
Turkey
Saudi Arabia
UAE
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Anti-acne Preparations manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Anti-acne Preparations in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.鈥�

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 Anti-acne Preparations 麻豆原创 Overview
1.1 Product Definition
1.2 Anti-acne Preparations by Type
1.2.1 Global Anti-acne Preparations 麻豆原创 Value Comparison by Type (2024-2030)
1.2.2 Erythromycin
1.2.3 Tretinoin
1.2.4 Adapalene
1.2.5 Benzoyl Peroxide
1.2.6 Clindamycin
1.2.7 Sulfur Ointment
1.2.8 Isotretinoin
1.3 Anti-acne Preparations by Application
1.3.1 Global Anti-acne Preparations 麻豆原创 Value by Application (2024-2030)
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Other
1.4 Global Anti-acne Preparations 麻豆原创 Size Estimates and Forecasts
1.4.1 Global Anti-acne Preparations Revenue 2019-2030
1.4.2 Global Anti-acne Preparations Sales 2019-2030
1.4.3 Global Anti-acne Preparations 麻豆原创 Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Anti-acne Preparations 麻豆原创 Competition by Manufacturers
2.1 Global Anti-acne Preparations Sales 麻豆原创 Share by Manufacturers (2019-2024)
2.2 Global Anti-acne Preparations Revenue 麻豆原创 Share by Manufacturers (2019-2024)
2.3 Global Anti-acne Preparations Average Price by Manufacturers (2019-2024)
2.4 Global Key Players of Anti-acne Preparations, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Anti-acne Preparations, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Anti-acne Preparations, Product Type & Application
2.7 Global Key Manufacturers of Anti-acne Preparations, Date of Enter into This Industry
2.8 Global Anti-acne Preparations 麻豆原创 Competitive Situation and Trends
2.8.1 Global Anti-acne Preparations 麻豆原创 Concentration Rate
2.8.2 The Global 5 and 10 Largest Anti-acne Preparations Players 麻豆原创 Share by Revenue
2.8.3 Global Anti-acne Preparations 麻豆原创 Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Anti-acne Preparations 麻豆原创 Scenario by Region
3.1 Global Anti-acne Preparations 麻豆原创 Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Anti-acne Preparations Sales by Region: 2019-2030
3.2.1 Global Anti-acne Preparations Sales by Region: 2019-2024
3.2.2 Global Anti-acne Preparations Sales by Region: 2025-2030
3.3 Global Anti-acne Preparations Revenue by Region: 2019-2030
3.3.1 Global Anti-acne Preparations Revenue by Region: 2019-2024
3.3.2 Global Anti-acne Preparations Revenue by Region: 2025-2030
3.4 North America Anti-acne Preparations 麻豆原创 Facts & Figures by Country
3.4.1 North America Anti-acne Preparations 麻豆原创 Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Anti-acne Preparations Sales by Country (2019-2030)
3.4.3 North America Anti-acne Preparations Revenue by Country (2019-2030)
3.4.4 United States
3.4.5 Canada
3.5 Europe Anti-acne Preparations 麻豆原创 Facts & Figures by Country
3.5.1 Europe Anti-acne Preparations 麻豆原创 Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Anti-acne Preparations Sales by Country (2019-2030)
3.5.3 Europe Anti-acne Preparations Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Anti-acne Preparations 麻豆原创 Facts & Figures by Region
3.6.1 Asia Pacific Anti-acne Preparations 麻豆原创 Size by Region: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Anti-acne Preparations Sales by Region (2019-2030)
3.6.3 Asia Pacific Anti-acne Preparations Revenue by Region (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Anti-acne Preparations 麻豆原创 Facts & Figures by Country
3.7.1 Latin America Anti-acne Preparations 麻豆原创 Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Anti-acne Preparations Sales by Country (2019-2030)
3.7.3 Latin America Anti-acne Preparations Revenue by Country
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.7.7 Colombia
3.8 Middle East and Africa Anti-acne Preparations 麻豆原创 Facts & Figures by Country
3.8.1 Middle East and Africa Anti-acne Preparations 麻豆原创 Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Anti-acne Preparations Sales by Country (2019-2030)
3.8.3 Middle East and Africa Anti-acne Preparations Revenue by Country
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Anti-acne Preparations Sales by Type (2019-2030)
4.1.1 Global Anti-acne Preparations Sales by Type (2019-2024)
4.1.2 Global Anti-acne Preparations Sales by Type (2025-2030)
4.1.3 Global Anti-acne Preparations Sales 麻豆原创 Share by Type (2019-2030)
4.2 Global Anti-acne Preparations Revenue by Type (2019-2030)
4.2.1 Global Anti-acne Preparations Revenue by Type (2019-2024)
4.2.2 Global Anti-acne Preparations Revenue by Type (2025-2030)
4.2.3 Global Anti-acne Preparations Revenue 麻豆原创 Share by Type (2019-2030)
4.3 Global Anti-acne Preparations Price by Type (2019-2030)
5 Segment by Application
5.1 Global Anti-acne Preparations Sales by Application (2019-2030)
5.1.1 Global Anti-acne Preparations Sales by Application (2019-2024)
5.1.2 Global Anti-acne Preparations Sales by Application (2025-2030)
5.1.3 Global Anti-acne Preparations Sales 麻豆原创 Share by Application (2019-2030)
5.2 Global Anti-acne Preparations Revenue by Application (2019-2030)
5.2.1 Global Anti-acne Preparations Revenue by Application (2019-2024)
5.2.2 Global Anti-acne Preparations Revenue by Application (2025-2030)
5.2.3 Global Anti-acne Preparations Revenue 麻豆原创 Share by Application (2019-2030)
5.3 Global Anti-acne Preparations Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Hefei Cube Pharmaceutical Co., Ltd.
6.1.1 Hefei Cube Pharmaceutical Co., Ltd. Company Information
6.1.2 Hefei Cube Pharmaceutical Co., Ltd. Description and Business Overview
6.1.3 Hefei Cube Pharmaceutical Co., Ltd. Anti-acne Preparations Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Hefei Cube Pharmaceutical Co., Ltd. Anti-acne Preparations Product Portfolio
6.1.5 Hefei Cube Pharmaceutical Co., Ltd. Recent Developments/Updates
6.2 Jiangsu Xinfu Pharmaceutical Co., Ltd.
6.2.1 Jiangsu Xinfu Pharmaceutical Co., Ltd. Company Information
6.2.2 Jiangsu Xinfu Pharmaceutical Co., Ltd. Description and Business Overview
6.2.3 Jiangsu Xinfu Pharmaceutical Co., Ltd. Anti-acne Preparations Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Jiangsu Xinfu Pharmaceutical Co., Ltd. Anti-acne Preparations Product Portfolio
6.2.5 Jiangsu Xinfu Pharmaceutical Co., Ltd. Recent Developments/Updates
6.3 Anhui Guosen Pharmaceutical Co., Ltd.
6.3.1 Anhui Guosen Pharmaceutical Co., Ltd. Company Information
6.3.2 Anhui Guosen Pharmaceutical Co., Ltd. Description and Business Overview
6.3.3 Anhui Guosen Pharmaceutical Co., Ltd. Anti-acne Preparations Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Anhui Guosen Pharmaceutical Co., Ltd. Anti-acne Preparations Product Portfolio
6.3.5 Anhui Guosen Pharmaceutical Co., Ltd. Recent Developments/Updates
6.4 Jiangsu Jibei Pharmaceutical Co., Ltd.
6.4.1 Jiangsu Jibei Pharmaceutical Co., Ltd. Company Information
6.4.2 Jiangsu Jibei Pharmaceutical Co., Ltd. Description and Business Overview
6.4.3 Jiangsu Jibei Pharmaceutical Co., Ltd. Anti-acne Preparations Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Jiangsu Jibei Pharmaceutical Co., Ltd. Anti-acne Preparations Product Portfolio
6.4.5 Jiangsu Jibei Pharmaceutical Co., Ltd. Recent Developments/Updates
6.5 Heilongjiang Fuhe Pharmaceutical Group Co., Ltd.
6.5.1 Heilongjiang Fuhe Pharmaceutical Group Co., Ltd. Company Information
6.5.2 Heilongjiang Fuhe Pharmaceutical Group Co., Ltd. Description and Business Overview
6.5.3 Heilongjiang Fuhe Pharmaceutical Group Co., Ltd. Anti-acne Preparations Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Heilongjiang Fuhe Pharmaceutical Group Co., Ltd. Anti-acne Preparations Product Portfolio
6.5.5 Heilongjiang Fuhe Pharmaceutical Group Co., Ltd. Recent Developments/Updates
6.6 Jiangsu Xiaolin Pharmaceutical Co., Ltd.
6.6.1 Jiangsu Xiaolin Pharmaceutical Co., Ltd. Company Information
6.6.2 Jiangsu Xiaolin Pharmaceutical Co., Ltd. Description and Business Overview
6.6.3 Jiangsu Xiaolin Pharmaceutical Co., Ltd. Anti-acne Preparations Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Jiangsu Xiaolin Pharmaceutical Co., Ltd. Anti-acne Preparations Product Portfolio
6.6.5 Jiangsu Xiaolin Pharmaceutical Co., Ltd. Recent Developments/Updates
6.7 Sichuan Mingxin Pharmaceutical Co., Ltd.
6.7.1 Sichuan Mingxin Pharmaceutical Co., Ltd. Company Information
6.7.2 Sichuan Mingxin Pharmaceutical Co., Ltd. Description and Business Overview
6.7.3 Sichuan Mingxin Pharmaceutical Co., Ltd. Anti-acne Preparations Sales, Revenue and Gross Margin (2019-2024)
6.7.4 Sichuan Mingxin Pharmaceutical Co., Ltd. Anti-acne Preparations Product Portfolio
6.7.5 Sichuan Mingxin Pharmaceutical Co., Ltd. Recent Developments/Updates
6.8 Jiangsu Fubang Pharmaceutical Co., Ltd.
6.8.1 Jiangsu Fubang Pharmaceutical Co., Ltd. Company Information
6.8.2 Jiangsu Fubang Pharmaceutical Co., Ltd. Description and Business Overview
6.8.3 Jiangsu Fubang Pharmaceutical Co., Ltd. Anti-acne Preparations Sales, Revenue and Gross Margin (2019-2024)
6.8.4 Jiangsu Fubang Pharmaceutical Co., Ltd. Anti-acne Preparations Product Portfolio
6.8.5 Jiangsu Fubang Pharmaceutical Co., Ltd. Recent Developments/Updates
6.9 Wuhan Nuoan Pharmaceutical Co., Ltd.
6.9.1 Wuhan Nuoan Pharmaceutical Co., Ltd. Company Information
6.9.2 Wuhan Nuoan Pharmaceutical Co., Ltd. Description and Business Overview
6.9.3 Wuhan Nuoan Pharmaceutical Co., Ltd. Anti-acne Preparations Sales, Revenue and Gross Margin (2019-2024)
6.9.4 Wuhan Nuoan Pharmaceutical Co., Ltd. Anti-acne Preparations Product Portfolio
6.9.5 Wuhan Nuoan Pharmaceutical Co., Ltd. Recent Developments/Updates
6.10 Fujian Yongan Pharmaceutical Co., Ltd.
6.10.1 Fujian Yongan Pharmaceutical Co., Ltd. Company Information
6.10.2 Fujian Yongan Pharmaceutical Co., Ltd. Description and Business Overview
6.10.3 Fujian Yongan Pharmaceutical Co., Ltd. Anti-acne Preparations Sales, Revenue and Gross Margin (2019-2024)
6.10.4 Fujian Yongan Pharmaceutical Co., Ltd. Anti-acne Preparations Product Portfolio
6.10.5 Fujian Yongan Pharmaceutical Co., Ltd. Recent Developments/Updates
6.11 Shanghai Zhengda General Pharmaceutical Co., Ltd.
6.11.1 Shanghai Zhengda General Pharmaceutical Co., Ltd. Company Information
6.11.2 Shanghai Zhengda General Pharmaceutical Co., Ltd. Description and Business Overview
6.11.3 Shanghai Zhengda General Pharmaceutical Co., Ltd. Anti-acne Preparations Sales, Revenue and Gross Margin (2019-2024)
6.11.4 Shanghai Zhengda General Pharmaceutical Co., Ltd. Anti-acne Preparations Product Portfolio
6.11.5 Shanghai Zhengda General Pharmaceutical Co., Ltd. Recent Developments/Updates
6.12 Jiangxi Hillconta Pharmaceutical Co., Ltd.
6.12.1 Jiangxi Hillconta Pharmaceutical Co., Ltd. Company Information
6.12.2 Jiangxi Hillconta Pharmaceutical Co., Ltd. Description and Business Overview
6.12.3 Jiangxi Hillconta Pharmaceutical Co., Ltd. Anti-acne Preparations Sales, Revenue and Gross Margin (2019-2024)
6.12.4 Jiangxi Hillconta Pharmaceutical Co., Ltd. Anti-acne Preparations Product Portfolio
6.12.5 Jiangxi Hillconta Pharmaceutical Co., Ltd. Recent Developments/Updates
6.13 Guangdong Hengjian Pharmaceutical Co., Ltd.
6.13.1 Guangdong Hengjian Pharmaceutical Co., Ltd. Company Information
6.13.2 Guangdong Hengjian Pharmaceutical Co., Ltd. Description and Business Overview
6.13.3 Guangdong Hengjian Pharmaceutical Co., Ltd. Anti-acne Preparations Sales, Revenue and Gross Margin (2019-2024)
6.13.4 Guangdong Hengjian Pharmaceutical Co., Ltd. Anti-acne Preparations Product Portfolio
6.13.5 Guangdong Hengjian Pharmaceutical Co., Ltd. Recent Developments/Updates
6.14 Guangdong China Resources Shunfeng Pharmaceutical Co., Ltd.
6.14.1 Guangdong China Resources Shunfeng Pharmaceutical Co., Ltd. Company Information
6.14.2 Guangdong China Resources Shunfeng Pharmaceutical Co., Ltd. Description and Business Overview
6.14.3 Guangdong China Resources Shunfeng Pharmaceutical Co., Ltd. Anti-acne Preparations Sales, Revenue and Gross Margin (2019-2024)
6.14.4 Guangdong China Resources Shunfeng Pharmaceutical Co., Ltd. Anti-acne Preparations Product Portfolio
6.14.5 Guangdong China Resources Shunfeng Pharmaceutical Co., Ltd. Recent Developments/Updates
6.15 Galderma
6.15.1 Galderma Company Information
6.15.2 Galderma Description and Business Overview
6.15.3 Galderma Anti-acne Preparations Sales, Revenue and Gross Margin (2019-2024)
6.15.4 Galderma Anti-acne Preparations Product Portfolio
6.15.5 Galderma Recent Developments/Updates
6.16 Bausch Health
6.16.1 Bausch Health Company Information
6.16.2 Bausch Health Description and Business Overview
6.16.3 Bausch Health Anti-acne Preparations Sales, Revenue and Gross Margin (2019-2024)
6.16.4 Bausch Health Anti-acne Preparations Product Portfolio
6.16.5 Bausch Health Recent Developments/Updates
6.17 Pure Source
6.17.1 Pure Source Company Information
6.17.2 Pure Source Description and Business Overview
6.17.3 Pure Source Anti-acne Preparations Sales, Revenue and Gross Margin (2019-2024)
6.17.4 Pure Source Anti-acne Preparations Product Portfolio
6.17.5 Pure Source Recent Developments/Updates
6.18 Zydus Lifesciences Ltd
6.18.1 Zydus Lifesciences Ltd Company Information
6.18.2 Zydus Lifesciences Ltd Description and Business Overview
6.18.3 Zydus Lifesciences Ltd Anti-acne Preparations Sales, Revenue and Gross Margin (2019-2024)
6.18.4 Zydus Lifesciences Ltd Anti-acne Preparations Product Portfolio
6.18.5 Zydus Lifesciences Ltd Recent Developments/Updates
6.19 Glenmark Pharmaceuticals
6.19.1 Glenmark Pharmaceuticals Company Information
6.19.2 Glenmark Pharmaceuticals Description and Business Overview
6.19.3 Glenmark Pharmaceuticals Anti-acne Preparations Sales, Revenue and Gross Margin (2019-2024)
6.19.4 Glenmark Pharmaceuticals Anti-acne Preparations Product Portfolio
6.19.5 Glenmark Pharmaceuticals Recent Developments/Updates
6.20 Sun Pharma
6.20.1 Sun Pharma Company Information
6.20.2 Sun Pharma Description and Business Overview
6.20.3 Sun Pharma Anti-acne Preparations Sales, Revenue and Gross Margin (2019-2024)
6.20.4 Sun Pharma Anti-acne Preparations Product Portfolio
6.20.5 Sun Pharma Recent Developments/Updates
6.21 Galderma Pharma SA
6.21.1 Galderma Pharma SA Company Information
6.21.2 Galderma Pharma SA Description and Business Overview
6.21.3 Galderma Pharma SA Anti-acne Preparations Sales, Revenue and Gross Margin (2019-2024)
6.21.4 Galderma Pharma SA Anti-acne Preparations Product Portfolio
6.21.5 Galderma Pharma SA Recent Developments/Updates
6.22 Alembic Pharmaceuticals
6.22.1 Alembic Pharmaceuticals Company Information
6.22.2 Alembic Pharmaceuticals Description and Business Overview
6.22.3 Alembic Pharmaceuticals Anti-acne Preparations Sales, Revenue and Gross Margin (2019-2024)
6.22.4 Alembic Pharmaceuticals Anti-acne Preparations Product Portfolio
6.22.5 Alembic Pharmaceuticals Recent Developments/Updates
6.23 CABTREO
6.23.1 CABTREO Company Information
6.23.2 CABTREO Description and Business Overview
6.23.3 CABTREO Anti-acne Preparations Sales, Revenue and Gross Margin (2019-2024)
6.23.4 CABTREO Anti-acne Preparations Product Portfolio
6.23.5 CABTREO Recent Developments/Updates
6.24 AdvaCare Pharma
6.24.1 AdvaCare Pharma Company Information
6.24.2 AdvaCare Pharma Description and Business Overview
6.24.3 AdvaCare Pharma Anti-acne Preparations Sales, Revenue and Gross Margin (2019-2024)
6.24.4 AdvaCare Pharma Anti-acne Preparations Product Portfolio
6.24.5 AdvaCare Pharma Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Anti-acne Preparations Industry Chain Analysis
7.2 Anti-acne Preparations Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Anti-acne Preparations Production Mode & Process
7.4 Anti-acne Preparations Sales and 麻豆原创ing
7.4.1 Anti-acne Preparations Sales Channels
7.4.2 Anti-acne Preparations Distributors
7.5 Anti-acne Preparations Customers
8 Anti-acne Preparations 麻豆原创 Dynamics
8.1 Anti-acne Preparations Industry Trends
8.2 Anti-acne Preparations 麻豆原创 Drivers
8.3 Anti-acne Preparations 麻豆原创 Challenges
8.4 Anti-acne Preparations 麻豆原创 Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 麻豆原创 Size Estimation
10.1.3 麻豆原创 Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer

Companies Mentioned:

Hefei Cube Pharmaceutical Co., Ltd.
Jiangsu Xinfu Pharmaceutical Co., Ltd.
Anhui Guosen Pharmaceutical Co., Ltd.
Jiangsu Jibei Pharmaceutical Co., Ltd.
Heilongjiang Fuhe Pharmaceutical Group Co., Ltd.
Jiangsu Xiaolin Pharmaceutical Co., Ltd.
Sichuan Mingxin Pharmaceutical Co., Ltd.
Jiangsu Fubang Pharmaceutical Co., Ltd.
Wuhan Nuoan Pharmaceutical Co., Ltd.
Fujian Yongan Pharmaceutical Co., Ltd.
Shanghai Zhengda General Pharmaceutical Co., Ltd.
Jiangxi Hillconta Pharmaceutical Co., Ltd.
Guangdong Hengjian Pharmaceutical Co., Ltd.
Guangdong China Resources Shunfeng Pharmaceutical Co., Ltd.
Galderma
Bausch Health
Pure Source
Zydus Lifesciences Ltd
Glenmark Pharmaceuticals
Sun Pharma
Galderma Pharma SA
Alembic Pharmaceuticals
CABTREO
AdvaCare Pharma

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.